DD283932A5 - Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur verhuetung von sexuell uebertragbaren krankheiten - Google Patents

Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur verhuetung von sexuell uebertragbaren krankheiten Download PDF

Info

Publication number
DD283932A5
DD283932A5 DD89330678A DD33067889A DD283932A5 DD 283932 A5 DD283932 A5 DD 283932A5 DD 89330678 A DD89330678 A DD 89330678A DD 33067889 A DD33067889 A DD 33067889A DD 283932 A5 DD283932 A5 DD 283932A5
Authority
DD
German Democratic Republic
Prior art keywords
tampon
pharmaceutical composition
gel
sexually transmitted
transmitted diseases
Prior art date
Application number
DD89330678A
Other languages
German (de)
English (en)
Inventor
Jacques Julien Augros
Original Assignee
����@����@���@��������@���������@�������@�������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����@����@���@��������@���������@�������@�������k�� filed Critical ����@����@���@��������@���������@�������@�������k��
Publication of DD283932A5 publication Critical patent/DD283932A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DD89330678A 1988-07-11 1989-07-11 Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur verhuetung von sexuell uebertragbaren krankheiten DD283932A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8809418 1988-07-11

Publications (1)

Publication Number Publication Date
DD283932A5 true DD283932A5 (de) 1990-10-31

Family

ID=9368330

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89330678A DD283932A5 (de) 1988-07-11 1989-07-11 Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur verhuetung von sexuell uebertragbaren krankheiten

Country Status (38)

Country Link
US (1) US5439685A (uk)
EP (1) EP0351301B1 (uk)
JP (1) JPH0774164B2 (uk)
KR (1) KR0143231B1 (uk)
CN (1) CN1035038C (uk)
AP (1) AP108A (uk)
AR (1) AR243381A1 (uk)
AT (1) ATE97570T1 (uk)
BR (1) BR8903523A (uk)
CA (1) CA1341304C (uk)
CZ (1) CZ280722B6 (uk)
DD (1) DD283932A5 (uk)
DE (1) DE68910892T2 (uk)
DK (1) DK173527B1 (uk)
ES (1) ES2062065T3 (uk)
FI (1) FI101595B (uk)
HK (1) HK131095A (uk)
HU (1) HU206634B (uk)
IE (1) IE63115B1 (uk)
IL (1) IL90910A (uk)
LT (1) LT3754B (uk)
LV (1) LV10573B (uk)
MA (1) MA22036A1 (uk)
MD (1) MD406C2 (uk)
MX (1) MX170801B (uk)
MY (1) MY106242A (uk)
NO (1) NO178843C (uk)
NZ (1) NZ229891A (uk)
OA (1) OA09123A (uk)
PL (1) PL161848B1 (uk)
PT (1) PT91108B (uk)
RU (1) RU2065742C1 (uk)
SK (1) SK423889A3 (uk)
TN (1) TNSN89074A1 (uk)
TR (1) TR28353A (uk)
UA (1) UA26124A (uk)
YU (1) YU47899B (uk)
ZA (1) ZA895263B (uk)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5693769A (en) * 1991-12-13 1997-12-02 Transcell Technologies, Inc. Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
US5795870A (en) * 1991-12-13 1998-08-18 Trustees Of Princeton University Compositions and methods for cell transformation
IT1255450B (it) * 1992-06-30 1995-10-31 Montefarmaco Spa Uso di acidi biliari come agenti antivirali
EP0773029A4 (en) * 1993-07-19 1997-09-03 Tokyo Tanabe Co HEPATITIS C VIRUS PROLIFERATION INHIBITOR
DE4341139C1 (de) * 1993-12-02 1995-04-13 Upmeyer Hans Juergen Dimeticon zur Behandlung von Aphthen
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US5700679A (en) * 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
GB2318292A (en) * 1996-09-12 1998-04-22 Simon Everard Barton Saliva-like protectants
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
ES2357474T3 (es) * 2000-03-07 2011-04-26 Rush-Presbyterian-St.Luke's Medical Center Composiciones y su uso para atrapar e inactivar microbios patógenos y espermatoziodes.
GB2415626B (en) * 2001-04-11 2006-03-08 Playtex Products Inc Use of a catamenial tampon which comprises a cationic surfactant for the treatment of vaginal malodor
US8093446B2 (en) * 2001-04-11 2012-01-10 Playtex Products, Inc. Fibrous absorbent articles having malodor counteractant
GB2412121B (en) * 2001-04-11 2006-01-11 Playtex Products Inc Tampon with malodour counteractant
ATE289514T1 (de) * 2003-11-03 2005-03-15 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
NZ565590A (en) * 2005-08-29 2010-07-30 Sepsicure L L C Use of a protein free composition comprising cholinic acid and a phosphosphlipid for the treatment or prevention of conditions caused by gram-positive bacteria
DE102006020644A1 (de) * 2006-04-28 2007-10-31 Bayer Innovation Gmbh Antiseptikahaltige Silikonelastomere
US8062631B2 (en) 2006-09-28 2011-11-22 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US8409557B2 (en) 2006-09-28 2013-04-02 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
AU2012203566B1 (en) * 2008-03-27 2013-09-12 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
KR101130754B1 (ko) 2010-06-25 2012-03-28 제일약품주식회사 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물
BR112013011744B1 (pt) 2010-11-12 2021-04-27 The University Of Utah Research Foundation Dispositivo intravaginal para distribuição controlada de lubrificantes
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
CA3079323A1 (en) 2011-04-19 2012-10-26 Arms Pharmaceutical Llc. Method of inhibiting harmful microorganisms and barrier-forming composition therefor
CA2781379C (en) 2012-03-26 2013-09-03 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
KR102399883B1 (ko) * 2021-02-09 2022-05-20 재단법인대구경북과학기술원 압출용 복합고분자 펠릿 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1161484A (en) * 1965-08-20 1969-08-13 Mediline Ag Toilet Preparation
SE353658B (uk) * 1967-06-13 1973-02-12 Dow Corning
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3770648A (en) * 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US4393871A (en) * 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4228797A (en) * 1978-09-25 1980-10-21 Dickey Richard P Intravaginal contraception method
ZA827582B (en) * 1981-11-06 1983-08-31 Ansell Inc Spermicidal condom
JPS58103453A (ja) * 1981-12-07 1983-06-20 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド １−置換イミダゾ−ルを放出する使い捨て膣内避妊具
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
AU2272883A (en) * 1982-12-22 1984-06-28 Herpes Pharmaceutical Inc. Pharmaceutical compositions of steriods for treatment of herpes simplex infections
DE3346641A1 (de) * 1983-12-23 1985-07-04 Dynamit Nobel Ag, 5210 Troisdorf Silanmodifizierte estergemische
GB8402748D0 (en) * 1984-02-02 1984-03-07 Dunlop Ltd Intravaginal device
NL8600929A (nl) * 1986-04-11 1987-11-02 Fundatech Sa Werkwijze voor het vervaardigen van een gemedicateerd wegwerp-pessarium en gemedicateerd wegwerp-pessarium.
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
US4952411A (en) * 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
GB8706313D0 (en) * 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
FR2614525B1 (fr) * 1987-04-29 1995-11-10 Jacques Augros Tampon en eponge elastique, notamment tampon vaginal
US4922928A (en) * 1988-08-17 1990-05-08 Michael Burnhill Vaginal device

Also Published As

Publication number Publication date
PL280531A1 (en) 1990-05-28
UA26124A (uk) 1999-06-07
LV10573B (en) 1995-08-20
FI893340A (fi) 1990-01-12
YU47899B (sh) 1996-05-20
IE892218L (en) 1990-01-11
EP0351301B1 (fr) 1993-11-24
PT91108A (pt) 1990-02-08
NZ229891A (en) 1991-01-29
DK173527B1 (da) 2001-01-29
NO892826L (no) 1990-01-12
AU625716B2 (en) 1992-07-16
FI101595B1 (fi) 1998-07-31
MY106242A (en) 1995-04-29
SK278614B6 (en) 1997-11-05
HK131095A (en) 1995-08-24
ATE97570T1 (de) 1993-12-15
YU135789A (en) 1992-05-28
EP0351301A2 (fr) 1990-01-17
KR900001366A (ko) 1990-02-27
KR0143231B1 (ko) 1998-07-15
PL161848B1 (pl) 1993-08-31
ES2062065T3 (es) 1994-12-16
CZ423889A3 (en) 1995-12-13
NO178843C (no) 1996-06-19
TNSN89074A1 (fr) 1991-02-04
ZA895263B (en) 1991-03-27
LV10573A (lv) 1995-04-20
OA09123A (fr) 1991-10-31
JPH02167235A (ja) 1990-06-27
MX170801B (es) 1993-09-14
IL90910A0 (en) 1990-02-09
LTIP1660A (en) 1995-07-25
DE68910892T2 (de) 1994-05-05
FI893340A0 (fi) 1989-07-10
NO892826D0 (no) 1989-07-07
DK340289A (da) 1990-01-12
CN1041879A (zh) 1990-05-09
BR8903523A (pt) 1991-11-05
US5439685A (en) 1995-08-08
RU2065742C1 (ru) 1996-08-27
MA22036A1 (fr) 1991-10-01
DE68910892D1 (de) 1994-01-05
NO178843B (no) 1996-03-11
DK340289D0 (da) 1989-07-10
HU206634B (en) 1992-12-28
SK423889A3 (en) 1997-11-05
HUT50445A (en) 1990-02-28
AP108A (en) 1991-02-23
IE63115B1 (en) 1995-03-22
CZ280722B6 (cs) 1996-04-17
AU3802689A (en) 1990-01-11
MD406C2 (ro) 1996-06-30
JPH0774164B2 (ja) 1995-08-09
AR243381A1 (es) 1993-08-31
CN1035038C (zh) 1997-06-04
AP8900133A0 (en) 1989-10-31
EP0351301A3 (en) 1990-12-19
TR28353A (tr) 1996-05-16
CA1341304C (fr) 2001-10-09
PT91108B (pt) 1995-01-31
LT3754B (en) 1996-03-25
FI101595B (fi) 1998-07-31
IL90910A (en) 1994-12-29

Similar Documents

Publication Publication Date Title
DD283932A5 (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur verhuetung von sexuell uebertragbaren krankheiten
DE69533724T2 (de) Zusammensetzung zum inaktivieren von reizstoffen in flüssigkeiten
DE69837348T2 (de) Verfahren zur inaktivierung von bakterien mit einbegriff von bakteriensporen
DE60105283T2 (de) Zusammensetzungen die molekulares iod enthalten
DE69729646T2 (de) Formulierung zur verwendung in der vorbeugung von pathogen-induzierten erkrankungen, einschliesslich hiv und hsv
DE69907664T2 (de) Verfahren zur Herstellung von wässrigen Formulierungen für ophthalmische Verwendung
DE69935325T2 (de) Formulierungen für die Prävention oder die Behandlung von Krankheiten, die Schleimhäute oder Haut betreffen oder für die Schwangerschaftsverhütung
DE2611725A1 (de) Zinksulfadiazin und dieses enthaltende dermatotherapeutische mittel zur behandlung von verbrennungen
DE69921119T2 (de) Verwendung von mikrobiziden und spermiziden zusammensetzungen zur inaktivierung von nichtumhüllten viren
DE3529397A1 (de) Fungizide zusammensetzung mit verlaengerter wirkungsdauer
DE60027209T2 (de) Behandlung von Knochengewebserkrankungen
CA2129652C (en) Aids prophylactic lubricatng composition and devices for its use
DE69532809T2 (de) Pharmazeutische präparate, insbesondere ovula, die viele verschiedene aktive bestandteile enthalten
WO1988007364A1 (en) New medicated ointment, process for its production, means of application using said ointment and production of said ointment
DD279408A5 (de) Verfahren zur herstellung einer substanz oder zusammenstetzung, die mindestens ein einzelliges lebewesen hemmt oder zerstoert
DE3710216A1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
DE2201357A1 (de) Osmotische Wirkstoffabgabevorrichtung
EP1196159B1 (de) Verwendung von tosylchloramid(en) zur behandlung von erkrankungen der haut, der schleimhaut, von organen und geweben
JP2559735B2 (ja) 抗ー微生物組成物
EP0403575B1 (de) Acyl-carnitin zur behandlung und zur verhütung von virusinfektionen
DE1669869A1 (de) Sanitaeres prophylaktisches Mittel
US4147785A (en) Method for the treatment of onchocerciasis
WO1998017229A2 (en) Medicament
HRP921074A2 (en) A process for the production of a preparation for preventing sexual deseases from spreading
DD148717A5 (de) Vaginal-tampon

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee